No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs550983465 |
chr4:8320978-8320979 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs528991765 |
chr4:8320979-8320980 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs544334543 |
chr4:8321018-8321019 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs572343857 |
chr4:8321048-8321049 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs73083686 |
chr4:8321060-8321061 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs115953137 |
chr4:8321072-8321073 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs370114294 |
chr4:8321080-8321081 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs145977058 |
chr4:8321155-8321156 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs562311767 |
chr4:8321195-8321196 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs4696811 |
chr4:8321215-8321216 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs551365732 |
chr4:8321227-8321228 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs557749789 |
chr4:8321257-8321258 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs560444764 |
chr4:8321307-8321308 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs527281889 |
chr4:8321322-8321323 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs548924283 |
chr4:8321334-8321335 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs139803205 |
chr4:8321348-8321349 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs537904719 |
chr4:8321350-8321351 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs544357110 |
chr4:8321364-8321365 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs571847307 |
chr4:8321425-8321426 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs539284179 |
chr4:8321430-8321431 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs6447860 |
chr4:8321456-8321457 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs182456887 |
chr4:8321474-8321475 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs527584510 |
chr4:8321491-8321492 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs536546275 |
chr4:8321494-8321495 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs533849618 |
chr4:8321509-8321510 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs141571367 |
chr4:8321522-8321523 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs187926795 |
chr4:8321666-8321667 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs193018677 |
chr4:8321679-8321680 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs565069315 |
chr4:8321692-8321693 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs4696812 |
chr4:8321709-8321710 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
31 |
rs150796704 |
chr4:8321768-8321769 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs139179203 |
chr4:8321803-8321804 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs560100454 |
chr4:8321805-8321806 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs527553253 |
chr4:8321827-8321828 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs9996392 |
chr4:8321865-8321866 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionlncRNA
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs567164827 |
chr4:8321929-8321930 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs560852352 |
chr4:8321948-8321949 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs73226013 |
chr4:8321959-8321960 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs551085192 |
chr4:8321986-8321987 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs4696813 |
chr4:8321994-8321995 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs532252451 |
chr4:8322010-8322011 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs547921359 |
chr4:8322014-8322015 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs566165993 |
chr4:8322045-8322046 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs149962001 |
chr4:8322071-8322072 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs57108914 |
chr4:8322083-8322084 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs184058036 |
chr4:8322090-8322091 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs569695653 |
chr4:8322091-8322092 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs144987224 |
chr4:8322135-8322136 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs558618313 |
chr4:8322193-8322194 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs377618527 |
chr4:8322195-8322196 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|